International Clinical Trial: Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After Trauma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07832331) titled 'Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After Trauma' on Sept. 16.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Milton S. Hershey Medical Center

Condition: Vocal Cord Paralysis Recurrent Laryngeal Nerve Palsy

Intervention: Drug: 4-Aminopyridine

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: December 1, 2026

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07832331...